TENUATE DOSPAN Drug Patent Profile
✉ Email this page to a colleague
When do Tenuate Dospan patents expire, and when can generic versions of Tenuate Dospan launch?
Tenuate Dospan is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenuate Dospan
A generic version of TENUATE DOSPAN was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENUATE DOSPAN?
- What are the global sales for TENUATE DOSPAN?
- What is Average Wholesale Price for TENUATE DOSPAN?
Summary for TENUATE DOSPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Patent Applications: | 643 |
| DailyMed Link: | TENUATE DOSPAN at DailyMed |
US Patents and Regulatory Information for TENUATE DOSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
